Kestra Medical Technologies - About the company
Kestra Medical Technologies is a public company based in Kirkland (United States), founded in 2014. It operates as a Device to protect and support patients at risk of cardiovascular disorders. Kestra Medical Technologies has raised $196M in funding from investors like Longitude Capital, Ally Bridge Group and Bain Capital Life Sciences. The company has 71 active competitors, including 23 funded and 21 that have exited. Its top competitors include companies like AtaCor Medical, EBR Systems and AtriCure.
Company Details
Kestra Medical Technologies provides medical technologies to protect and support patients at risk. The company focuses on the development of external defibrillation, implantable cardiac rhythm devices, and the class III medical device. The company is looking forward to partnering with technology providers consumer wearables, wireless, and class III therapeutic medical devices.
- Website
- kestramedical.com
- Email ID
- *****@kestramedical.com
- Phone Number
- +1 **********
- Registered Address
- Kirkland, Washington
Key Metrics
Founded Year
2014
Location
Kirkland, United States
Stage
Public
Total Funding
$196M in 2 rounds
Latest Funding Round
Investors
Ranked
6th among 71 active competitors
Employee Count
544 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Kestra Medical Technologies
Kestra Medical Technologies is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Kestra Medical Technologies, Inc. CIN: 20231141209 , United States, Active | Feb 02, 2023 | - | - | - |
KESTRA MEDICAL TECHNOLOGIES IN CIN: 383940333 , United States, Active | Dec 26, 999 | - | 312 (As on Dec 31, 2024) | - |
Kestra Medical Technologies's IPO details
Kestra Medical Technologies got listed on Mar 06, 2025.
Click here to take a look at Kestra Medical Technologies's IPO in detail
Sign up to download Kestra Medical Technologies' company profile
Kestra Medical Technologies's funding and investors
Kestra Medical Technologies has raised a total funding of $196M over 2 rounds. Its first funding round was on 2014. Its latest funding round was a Series B round on Jul 24, 2024 for $*****. 9 investors participated in its latest round. Kestra Medical Technologies has 11 institutional investors.
Here is the list of recent funding rounds of Kestra Medical Technologies:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 24, 2024 | 2337630 | Series B | 2194581 | 9259497 | 1314340 | 1004134 |
2014 | 7111 | Series A | 7069 | 2052 | 2453 |
View details of Kestra Medical Technologies's funding rounds and investors
Kestra Medical Technologies' founders and board of directors
Founder? Claim ProfileKestra Medical Technologies' employee count trend
Kestra Medical Technologies has 544 employees as of Sep 26. Here is Kestra Medical Technologies's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Kestra Medical Technologies's Competitors and alternates
Top competitors of Kestra Medical Technologies include AtaCor Medical, EBR Systems and AtriCure. Here is the list of Top 10 competitors of Kestra Medical Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AtaCor Medical 2014, San Clemente (United States), Series D | Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions | $137M | 64/100 | |
2nd | EBR Systems 2003, Sunnyvale (United States), Public | Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure | $180M | 60/100 | |
3rd | AtriCure 2000, Mason (United States), Public | Medical device company focused on atrial fibrillation and pain management | - | 59/100 | |
4th | CardioFocus 1990, Marlborough (United States), Series E | Endoscopically guided catheter for ablation | $261M | 58/100 | |
5th | CathVision 2013, Copenhagen (Denmark), Series B | Provider and developer of an AI-based cardiac ablation therapy software and device | $36.1M | 57/100 | |
6th | Kestra Medical Technologies 2014, Kirkland (United States), Public | Device to protect and support patients at risk of cardiovascular disorders | $196M | 54/100 | |
7th | TyRx 1998, Monmouth Junction (United States), Acquired | Antibacterial envelopes for cardiac implants | $70.8M | 47/100 | |
8th | Cameron Health 2001, San Clemente (United States), Acqui-Hired | Subcutaneous Implantable Defibrillator | $158M | 45/100 | |
9th | nContact Surgical 2005, Morrisville (United States), Acquired | Cardiac ablation technology | $53.2M | 45/100 | |
10th | Append Medical 2016, Or Yehuda (Israel), Series A | Developer of a device for the left atrial appendage closure system | $11.8M | 45/100 |
Looking for more details on Kestra Medical Technologies's competitors? Click here to see the top ones
Kestra Medical Technologies's Investments and acquisitions
Kestra Medical Technologies has made no investments or acquisitions yet.
Reports related to Kestra Medical Technologies
Here is the latest report on Kestra Medical Technologies's sector:
News related to Kestra Medical Technologies
Media has covered Kestra Medical Technologies for a total of 16 events in the last 1 year, 4 of them have been about company updates and 1 about partnerships.
•
Kestra Medical Technologies Earns Five-Star Rating on Newsweek's List of America's Greatest Mid-Market CompaniesGlobeNewswire•Oct 01, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial ResultsGlobeNewswire•Sep 15, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies Names Daniel Finney Vice President of Research & DevelopmentGlobeNewswire•Sep 10, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial ResultsManilatimes•Jul 15, 2026•Kestra Medical Technologies
•
Kestra Medical, Ltd. GAAP EPS of -$0.67 misses by $0.07, revenue of $28.6M beats by $2.12MSeeking Alpha•Jul 14, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies (NASDAQ:KMTS) Trading Up 7.5% – Should You Buy?Themarketsdaily•Jul 01, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of “Hold” by AnalystsWatch List News•Jun 24, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award WinnerGlobeNewswire•Apr 09, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies Reports Q3 Fiscal 2026 Financial ResultsGlobeNewswire•Mar 17, 2026•Kestra Medical Technologies
•
Kestra Medical Technologies and Biobeat Technologies Collaborate to Expand Diagnostic InsightGlobeNewswire•Jan 13, 2026•Kestra Medical Technologies, Biobeat
Are you a Founder ?
FAQs about Kestra Medical Technologies
Explore our recently published companies
- Carolina Technologies - Charlotte based, Unfunded company
- Utkal MFC - Bhubaneswar based, 1996 founded, Unfunded company
- FutureCast Media - Unfunded company
- apc analytics - Germany based, 1986 founded, Unfunded company
- EMAGINE CREATIONS - Fort Lauderdale based, 2008 founded, Public company
- Paint Force 1 - Unfunded company